Tag: Teveten

Teveten is the brand name for eprosartan, but this medication is no longer available in the United States, having been discontinued for business reasons, not safety concerns. This angiotensin II receptor blocker was once used to treat high blood pressure.

High blood pressure is a common condition that, if untreated, can damage the brain, heart, and kidneys [1.7.7]. For years, eprosartan helped manage this, so many patients are now asking: **why was eprosartan discontinued?** The answer is clearer than you might think.

Eprosartan is not a beta blocker, but an Angiotensin II Receptor Blocker (ARB) used to treat hypertension. These two distinct medication classes lower blood pressure through completely different mechanisms, targeting separate pathways within the body's cardiovascular system.

Eprosartan, an angiotensin II receptor blocker (ARB) once available under the brand name Teveten, was primarily used for treating high blood pressure (hypertension). By relaxing blood vessels, this medication effectively lowered blood pressure and reduced the risk of serious cardiovascular events like heart attacks and strokes. This guide will explore what is the drug eprosartan used for, its mechanism, and its place in pharmacology, particularly in light of its discontinuation in certain markets like the United States for business reasons.

As an angiotensin II receptor blocker, eprosartan is distinguished by its unique, non-biphenyl, non-tetrazole chemical structure. The action of eprosartan involves a dual mechanism to lower blood pressure effectively, targeting the renin-angiotensin system (RAS) and inhibiting norepinephrine production. This comprehensive overview details the pharmacological specifics of this antihypertensive medication.